Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

AT-7519 doses correlated with markers of CDK inhibition in solid tumor trial

May 20, 2009

Merck & Co. presents novel JAK and PDK1 kinase inhibitors for cancer treatment

May 19, 2009

Finland approves Ark's Cerepro for treatment on named-patient basis

May 19, 2009

ERYtech initiates recruitment for phase II clinical trial of Graspa for ALL

May 19, 2009

COTI-2 plus Taxol superior to Taxol alone in animal cancer model

May 19, 2009

DNA alkylating agent BO-1062 selected for further development

May 19, 2009

Data from first-in-human trial of MK-0752 reported

May 19, 2009

Intellikine describes dual mTORC1/2 inhibitor INK-128

May 19, 2009

Avila Therapeutics presents on Btk inhibitor AVL-291, pan-ErbB inhibitor CNX-222 at AACR

May 19, 2009

Nonsteroidal antiandrogen shows efficacy in castration-resistant prostate cancer in phase I/II trial

May 18, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...